Back to search
Low Risk Prostate Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Low Risk Prostate Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Low Risk Prostate Cancer trials you may qualify forThe goal of this clinical trial is to learn if a low to moderate load power training program is feasible and effective for improving fitness and quality of life…
This phase IV trial studies the effects of testosterone replacement therapy (TRT) on treatment outcomes in hypogonadal men with prostate cancer that has not spr…
This is a Phase II, single arm, multi-centre, prospective clinical trial evaluating next generation Stereotactic Ablative Radiotherapy (SABR) for low, intermedi…
PSMA is an ideal target for precision diagnosis and treatment of prostate cancer. P17-088 is a novel albumin-binding PSMA-targeted radioligand. This study aims…
This is an observational study in which medical records of Japanese men with low-volume metastatic hormone-sensitive prostate cancer (mHSPC), who received treat…
The study will be conducted in 4 parts and will commence with dose escalation of VIR-5500 as a monotherapy (Part 1), followed by combination escalation (Part 3a…
The purpose of this study is to collect information on how patients and their partners/close allies make treatment decisions when they have been diagnosed with…
This phase III trial uses the Decipher risk score to guide therapy selection. Decipher score is based on the activity of 22 genes in prostate tumor and may pred…